RE: BusinessWeekly Prometic IPO article
I would bet that the percentage retained by PLI will all be a function of whether there are any forward royalties involved on sale or whether there is actually any cash transaction for the rights to the technology.... or whether its a straight stock transaction.... its definitely complicated...
My point is... its all good if the market cap is anywhere near where its suggested it will be.... Just look at the remaining implied value of the PPPS Technology and Therapeutics... 1402 , 1393 etc... AND.. existing shareholders retain exposure to a well funded UK division with no further overhead drag.